-
Drug Discovery & Therapeutics2 months agoClick chemistry platform enhances ADC tumour targeting
Nature Reviews Drug Discovery, Published online: 02 September 2026; doi:10.1038/d41573-026-00146-xClick chemistry platform enhances ADC tumour targeting
-
Drug Discovery & Therapeutics2 months agoOno Pharmaceutical joins forces with Aitia for drug discovery in neurology
The agreement will see Aitia apply its REFS technology to build Gemini Digital Twins (GDTs) of neurological conditions to identify potential new therapeutic targets and biomarkers....
-
Drug Discovery & Therapeutics2 months agoSolute carrier membrane transporters: emerging targets in CNS disorders
Nature Reviews Drug Discovery, Published online: 01 September 2026; doi:10.1038/s41573-026-01513-4Solute carrier transporters are critical for maintaining central nervous system homeostasis, and their dysregulation is implicated in...
Clinical Trials & Development13 hours ago
Genmab’s cancer bispecific delivers early survival win in ‘exceedingly positive’ Phase 3 readout
Clinical Trials & Development13 hours ago
Genmab’s cancer bispecific delivers early OS win in ‘exceedingly positive’ Phase 3 readout
Helixgate Featured14 hours ago
STAT+: HHS moves to allow compounding of some unapproved peptides
Uncategorized7 months ago
Novartis buys Synnovation’s PI3Kα inhibitors for $3 billion
Endpoints News7 months ago
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
Uncategorized6 months ago
